| |
|
|
|
Catabasis Pharmaceuticals Inc.  
|
|
7.42 -0.07 (-0.01%) |
07-15 16:00 |
|
Open: |
7.56 |
Pre close: |
7.49 |
Target:
|
9.57
|
|
High: |
7.73 |
Low: |
7.31 |
Resistance:
|
8.19
9.57
|
|
Volume: |
48,180 |
Market Cap: |
85M |
Support:
|
6.63
5.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.56
 |
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
7.43  |
Signal(12,26,9): |
0.15 |
|
MA(100): |
7.14 |
Stochastic Oscillator |
%K(14,3):
|
25.20 |
|
MA(250): |
6.72 |
%D(3): |
43.68 |
|
Average Volume(K) |
3-Month: |
9499
|
52-Week |
High:
|
9.76 |
|
10-Days: |
5414 |
Low: |
3.60 |
|
RSI |
RSI(14):
|
52.08 |
Change(%): |
-9.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.560 |
Return on Equity (ttm) |
-77.3 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-41.5 |
Shares Float (M) |
10.89 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.87 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
33.18 |
|
Forward EPS |
-1.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
593 |
|
Book Value (p.s.) |
4.340 |
EBITDA (p.s.) |
-2.096 |
P/E |
-2.08 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.71 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.23 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.04 |
P/CF |
-0.00 |
|
|
|
|
|
|
